Last CNY13.65 CNY
Change Today +0.03 / 0.22%
Volume 3.2M
300239 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 2:00 AM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

baotou dongbao bio-tech co-a (300239) Snapshot

Open
CNY13.59
Previous Close
CNY13.62
Day High
CNY13.89
Day Low
CNY13.30
52 Week High
12/4/14 - CNY16.50
52 Week Low
05/9/14 - CNY9.25
Market Cap
2.7B
Average Volume 10 Days
5.3M
EPS TTM
CNY0.22
Shares Outstanding
197.5M
EX-Date
06/12/14
P/E TM
62.0x
Dividend
CNY0.08
Dividend Yield
0.59%
Current Stock Chart for BAOTOU DONGBAO BIO-TECH CO-A (300239)

Related News

No related news articles were found.

baotou dongbao bio-tech co-a (300239) Related Businessweek News

No Related Businessweek News Found

baotou dongbao bio-tech co-a (300239) Details

Baotou Dongbao Bio-Tech Co., Ltd. engages in the research, development, manufacture, and distribution of gelatin series products and low molecular mass collagen in China and internationally. The company provides photosensitive gelatin used in photographic materials production; pharmaceutical gelatin for use in the manufacture of soft and hard capsules, drugs, suppositories, plasma substitutes, sugar-coated tablets, surgical powders, gelatin dressings, gelatin sponges, cosmetics, health products, and others; and edible gelatin for use in candies, desserts, cold drinks, jellies, skin cold, drinks, sausages, canned foods, wines, fruit juice clarification, meat products, dairy processing, and catering and other food industries. It also offers collagen for use in food, cosmetics, functional health products, and other fields; and DCP for use in animal feed, animal husbandry, and other related industries. Baotou Dongbao Bio-Tech Co., Ltd. was founded in 1997 and is based in Baotou, China.

Founded in 1997

baotou dongbao bio-tech co-a (300239) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

baotou dongbao bio-tech co-a (300239) Key Developments

Baotou Dongbao Bio-Tech Co., Ltd. Announces Earnings Results for the First Three Quarters of 2014

Baotou Dongbao Bio-tech Co. Ltd. announced earnings results for the first three quarters of 2014. The company revealed operating revenue of CNY 173 million in the first three quarters, declining 41.6% from a year earlier. Net profit attributable to shareholders reached CNY 3.189 million, lessening 90.56%.

Baotou Dongbao Bio-Tech Co.,Ltd Provides Earnings Guidance for the First Three Quarter of 2014

Baotou Dongbao Bio-Tech Co.,Ltd provided earnings guidance for the first three quarter of 2014. For the period, the company expected net profit attributable to shareholders to be in the range of CNY 2.6 million to CNY 4 million, declining 88.16% to 92.31% from CNY 33.7926 million a year earlier.

Baotou Dongbao Bio-Tech Co.,Ltd to Report Q3, 2014 Results on Oct 24, 2014

Baotou Dongbao Bio-Tech Co.,Ltd announced that they will report Q3, 2014 results on Oct 24, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300239:CH CNY13.65 CNY +0.03

300239 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300239.
View Industry Companies
 

Industry Analysis

300239

Industry Average

Valuation 300239 Industry Range
Price/Earnings 100.0x
Price/Sales 10.4x
Price/Book 7.9x
Price/Cash Flow 221.9x
TEV/Sales 9.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAOTOU DONGBAO BIO-TECH CO-A, please visit www.dongbaoshengwu.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.